Diabetes treatment is constantly advancing, with new therapeutic options developing to improve patient outcomes. Recent research have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions https://junaidmgqs736688.gynoblog.com/37914788/novel-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment